David J. Franklin

Corporate Officer/Principal at Intarcia Therapeutics, Inc.

Health Technology

Consumer Services

Profile

David J.
Franklin is currently the Vice President-Alliance Management & Advocacy at Intarcia Therapeutics, Inc. He previously worked as a Senior Vice President-Global Marketing at Idenix Pharmaceuticals LLC from 1998 to 2006 and as a Product Manager at Bristol Myers Squibb Co. from 1990 to 1995.
Mr. Franklin received his undergraduate degree from Gettysburg College in 1988.

David J. Franklin active positions

Companies	Position	Start
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.	Corporate Officer/Principal	28/02/2006

All active positions of David J. Franklin

Former positions of David J. Franklin

Companies	Position	End
IDENIX PHARMACEUTICALS INC	Sales & Marketing	29/03/2006
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	31/12/1994

See the detail of David J. Franklin's experience

Training of David J. Franklin

Gettysburg College

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David J. Franklin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Private companies	2
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.	Health Technology
Idenix Pharmaceuticals LLC Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA.	Health Technology